REVIEW OF RESOLAB FMD SUBNETWORK ACTIVITIES

REVIEW OF RESOLAB FMD SUBNETWORK ACTIVITIES

• 1.
  REVIEW OF RESOLABFMD SUBNETWORK ACTIVITIES DR. Joseph ADONGO AWUNI, Accra Veterinary Laboratory, ACCRA, GHANA
• 2.
  ORDER OF PRESENTATION RESOLAB STRUCTURE & ACTIVITIES  ESTABLISHMENT OF SUBNETWORKS  RABIES, PPR & FMD  ACTIVITIES & OUTPUT OF FMD SUBNETWORK  RESULTS OF INFORMATION COLLATED  DEDUCTION FROM SUBNETWORK ACTIVITIES  WAY FORWARD
• 3.
  RESOLAB STRUCTURE & ACTIVITIES FORMATION  RESOLAB is the WEST & CENTRAL AFRICA Veterinary Laboratories network for Avian influenza and TADs launched in Dec 2007  Response to the outbreak and fast spreading of HPAI / H5N1 in 2006 to harmonize control and surveillance activities for the disease and other TADs  Coordination Unit – FAO-ECTAD at the Regional Animal Health Centre in BAMAKO, Mali and covers this area.
• 4.
  RESOLAB AREA  RESOLAB23 LABORATORIES
• 5.
  ESTABLISHMENT •In 2010 thenetwork formed subnetworks for a number of priority diseases such as FMD, Rabies & PPR, with focal persons in member states & animators • with the aim of • harmonizing & enhancing surveillance and diagnostic activities, • collation of information on the situation of the diseases within the area •submission of sample for pathogen identification and characterization •In the long term establish the most effective control/ eradication measures within the area RESOLAB SUBNETWORKS
• 6.
  • Over theyears, the subnetwork collated information on FMD situation from focal persons  Number of reported FMD outbreaks  Number/types of samples collected  Type of tests conducted  Serotypes detected  Capacities of labs to diagnose FMD  Number of samples sent to reference labs for confirmation  Control measure employed (type of vaccine) FMD SUBNETWORK ACTIVITIES
• 7.
  FMD SUBNETWORK OUTPUTS No.Country No. of FMD outbreaks / serotypes 2010 2011 2012 1 BENIN 39, O, A, SAT 1 & 2 22; O, A, SAT 1 & 2 No information 2 Burkina Faso 32; no virus 13; no virus No information 3 CAPE VERD No information No information No information 4 CAR No information No information No information 5 CHAD No information No information No information 6 CAMEROON No information 35; not tested 11; SAT 2 7 CONGO No information No information No information 8 Cote D’Ivoire 15; no virus 10; no virus No information
• 8.
  FMD SUBNETWORK OUTPUTS No.Country No. of FMD outbreaks / serotypes 2010 2011 2012 9 D. R. CONGO No information 3; not tested No information 10 Eq. Guinea No information No information No information 11 GABON No info No info No info 12 The GAMBIA No outbreak No outbreak 3; SAT 13 GHANA 39; No virus 43 sera positive - O 3, serotype O 14 GUINEA BISSAU No information No information No information 15 GUINEA CONAKRY No information No information No information 16 LIBERIA No information No information No information 17 MALI 4, no virus 1, SAT2 No information 18 NIGER No information No information No information
• 9.
  FMD SUBNETWORK OUTPUTS No.Country No. of FMD outbreaks / serotypes 2010 2011 2012 19 NIGERIA 17, no virus 10:- O, A, SAT2 > 50:- A, O, SAT1 & SAT2 20 Sao Tome & Principe No information No information No information 21 SENEGAL 6; not tested 12; SAT 2 15; A, SAT 1, SAT 2 22 SIERRA LEONE No outbreak No outbreak No outbreak 23 TOGO 42; O, SAT 1 No Information 1; serotype O
• 10.
  • 2011 :- •EUFMD agreement • Collated information into quarterly & annual report which were shared with FAO/ RESOLAB • CAPACITY FOR FMD DIAGNOSIS • Few of the 23 labs have been active in FMD diagnosis • Few have established molecular (PCR) as well as serological techniques (ELISA) that can be applied • DEDUCTION • Inadequate diagnostic capacity of member states laboratories for FMD FMD SUBNETWORK OUTPUT
• 11.
  • No wideinvolvement in FMD-PT like for AI/ND & PPR • EUFMD, FAO/IDENTIFY, USAID sponsored training conducted at the Accra veterinary laboratory (17-21 September 2012) • Participants were from 9- countries in RESOLAB Area • The resource persons were Dr. Kees Van Maanen & Dr. Labib Bakkali-Kassimi • Clinical samples for Nigeria, Cameroon and Ghana were used for the practical sessions • After the training Ag-detection ELISA kits and some aliquots of primers were distributed to some of the participating labs TRAINING IN FMD DIAGNOSIS
• 12.
  Lecture sessions
• 13.
  Practical sessions
• 14.
  • FMD isendemic in the RESOLAB area • Generally lab capacity for the diagnosis of the disease is lacking • Most frequently detected serotypes are O, A, SAT 1 & SAT 2 • No concrete control strategy is in place in most member states (Stage o of the PCP) CONCLUSION
• 15.
  FMD distribution byserotypes with possibility of epidemic jumps between pools 15
• 16.
  • • A goodnumber of labs now have some appreciable level of capacity for FMD Diagnosis • Establish the true status of FMD in member states • analysis of clinical samples • Retrospective testing of stored sera • Further strengthening the diagnostic capacities of the laboratories, and • will help to get national authorities sensitized to commence control measures along the PCP THE WAY FORWARD
• 17.
  • • Improve informationcollation from focal persons • Increase collaboration with epidemiology & laboratory for increased sample submissions to national labs • Submission of clinical samples to ref. Labs for FMDv isolation and characterization • Improved laboratory diagnosis of FMD • Improved reporting to national authorities on the situation of FMD in the country • Sensitize the relevant authorities into advancing control of the disease along the PCP • Effective quarterly reporting of FMD activities to RESOLAB Coordination unit and FAO -ROME • Funding available; conduct a PT on FMD diagnosis for member labs as a way of assessing the effectiveness of the trainings THE WAY FORWARD
• 18.
  ACKNOWLEDGEMENT & DEDICATION